For instance, EFNA3/EPHA2 axis can promote cancer stemness in hypoxic hepatocellular carcinoma by modulating metabolic plasticity, and EFNA3 is served as a prognostic biomarker for hepatocellular cancer [47, 48]. The gene discussed is EPHA2; the disease is hepatocellular carcinoma.